EAGLE VETERINARY TECHNOLOGY CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,290 KRW | +1.15% |
|
+2.52% | -3.82% |
| Sales 2022 | 43.54B 32.13M 43.93M | Sales 2023 | 42.79B 31.58M 43.18M | Capitalization | 69.53B 51.31M 70.16M |
|---|---|---|---|---|---|
| Net income 2022 | 2.64B 1.95M 2.67M | Net income 2023 | 2.98B 2.2M 3M | EV / Sales 2022 | 1.62 x |
| Net Debt 2022 | 1.56B 1.15M 1.58M | Net Debt 2023 | 1.47B 1.08M 1.48M | EV / Sales 2023 | 1.66 x |
| P/E ratio 2022 |
25.4
x | P/E ratio 2023 |
22.7
x | Employees | 65 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.7% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.15% | ||
| 1 week | +2.52% | ||
| Current month | +1.15% | ||
| 1 month | +0.95% | ||
| 3 months | +1.73% | ||
| 6 months | +2.32% | ||
| Current year | -3.82% |
1 week
5 170.00
5 310.00
1 month
5 080.005 580.00
Current year
5 040.005 960.00
1 year
4 800.007 750.00
3 years
4 800.009 700.00
5 years
3 160.0013 200.00
10 years
3 160.0013 200.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tae-Seong Gang
CEO | Chief Executive Officer | 55 | - |
Seung-Jo Gang
CEO | Chief Executive Officer | 87 | - |
Young-Ja Kim
AUD | Comptroller/Controller/Auditor | 82 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Seung-Jo Gang
CEO | Chief Executive Officer | 87 | - |
Tae-Seong Gang
CEO | Chief Executive Officer | 55 | - |
Yong-Moon Kang
BRD | Director/Board Member | 65 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 5,260 | -0.57% | 39,602 |
| 24-05-02 | 5,290 | +1.15% | 66,023 |
| 24-04-30 | 5,230 | +0.38% | 46,027 |
| 24-04-29 | 5,210 | +0.39% | 36,777 |
| 24-04-26 | 5,190 | +0.58% | 44,114 |
End-of-day quote Korea S.E., May 01, 2024
More quotes
Eagle Veterinary Technology Co.,Ltd is a Korea-based company engaged in the manufacture and marketing of veterinary medicines. The Companyâs main products are veterinary medicines, including anthelmintics, antibiotics, analgesic agents, antibacterials, anti-inflammatory agents, disinfectants, probiotics, nutrients and others in the forms of soluble powders, oral liquids, oral tablets and injections. The Companyâs products are used for bovine, swine, poultry, fishes and companion animals. It also engages in the leasing of real estate. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -3.82% | 48.8M | |
| -8.96% | 6.64B | |
| +24.75% | 3.7B | |
| -1.11% | 3.12B | |
| +6.08% | 1.45B | |
| -15.13% | 1.37B | |
| -25.63% | 1.24B | |
| -7.62% | 1.21B | |
| -10.84% | 1.17B | |
| -.--% | 1.05B |
- Stock Market
- Equities
- A044960 Stock
